Valuation (40%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 49.34 | 22.80 |
| PEG Ratio (TTM) | -0.72 | 4.35 |
| P/S Ratio (TTM) | 0.99 | 2.17 |
| P/B Ratio (TTM) | 2.38 | 2.59 |
| P/FCF Ratio (TTM) | -11.71 | 14.75 |
| Price to 5YR AVG Earnings Ratio | 13.40 | 6.93 |
| Price to 5YR AVG FCF Ratio | 198.05 | 32.74 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.17% | 6.87% |
| ROE (TTM) | 4.87% | 4.53% |
| Net Profit Margin (TTM) | 1.95% | 7.30% |
| ROIC 5YR AVG | 6.44% | 9.57% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -41.88% | 633.91% | 395.05% |
| Revenue | 3.92% | 8.50% | 7.58% |
| Net Income | -45.20% | 804.15% | 490.92% |
| Cash Flow | 60.82% | 817.41% | 1,030.63% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 2.37 |
| Quick Ratio (TTM) | 1.75 | 2.27 |
| D/E Ratio (TTM) | 0.89 | 0.27 |
| Interest Coverage (TTM) | 6.74 | 139.93 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 2.86 | 4.41 |
| LTL to 5YR AVG FCF | 51.57 | 1.73 |
| Shares Outstanding Growth 5YR AVG | 4.44% | 31.11% |